Evidence map›Paper›PMID 32036560›Full record

ArticleTranslational stroke research2020

FasL-PDPK1 Pathway Promotes the Cytotoxicity of CD8

Lizhen Fan, Cun-Jin Zhang, Liwen Zhu, Jian Chen, Zhi Zhang, Pinyi Liu, Xiang Cao, Hailan Meng, Yun Xu

Abstract read
PubMed Publisher
In one paragraph

Article in Translational stroke research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Targeting TMEM175 in Lysosomal Physiology and Human Diseases.Current stem cell research & therapy · 2026
    Review
  5. Review
  6. CD8Cellular & molecular immunology · 2025
    Article
  7. Article
  8. Review
  9. Review
  10. The High-Affinity IL-2 Receptor Affects White Matter Damage after Cerebral Ischemia by Regulating CD8 + T Lymphocyte Differentiation.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2025
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Highlighting a New Potential Target in Stroke: Immunoreceptor NKG2D.Journal of the American Heart Association · 2023
    Article
  18. Review
  19. CD8Frontiers in cellular neuroscience · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Lizhen Fan *Department of Neurology, Drum Tower Hospital, Medical School and The State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, 210008, China.
Cun-Jin Zhang *Department of Neurology, Drum Tower Hospital, Medical School and The State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, 210008, China.
Liwen ZhuDepartment of Neurology, Drum Tower Hospital, Medical School and The State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, 210008, China.
Jian ChenDepartment of Neurology, Drum Tower Hospital, Medical School and The State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, 210008, China.
Zhi ZhangDepartment of Neurology, Drum Tower Hospital, Medical School and The State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, 210008, China.
Pinyi LiuDepartment of Neurology, Drum Tower Hospital, Medical School and The State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, 210008, China.
Xiang CaoDepartment of Neurology, Drum Tower Hospital, Medical School and The State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, 210008, China.
Hailan MengDepartment of Neurology, Drum Tower Hospital, Medical School and The State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, 210008, China.
Yun XuDepartment of Neurology, Drum Tower Hospital, Medical School and The State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, 210008, China. xuyun20042001@aliyun.com.
Nanjing Drum Tower Hospital · CNNanjing University · CNJiangsu Province Blood Center · CN

Funding

National Natural Science Foundation of China 81230026National Natural Science Foundation of China 81630028National Natural Science Foundation of China 81701168National Natural Science Foundation of China 81701235Science and Technology Support Program of Jiangsu Province BE2016610
6 · The paper itself

Abstract

CD8

Indexed as

3-Phosphoinositide-Dependent Protein KinasesAnimalsApoptosisBrain IschemiaCD8-Positive T-LymphocytesFas Ligand ProteinIschemic StrokeMaleMice, Inbred C57BLMice, TransgenicNeuronsSignal Transduction3-Phosphoinositide-Dependent Protein KinasesFas Ligand ProteinFasl protein, mousePdpk1 protein, mouseCD8+ T cellscytotoxicityFasLneuronsPDPK1stroke

Identifiers

PMID32036560
OpenAlexW3004580045

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.